Last Price
0.024
Today's Change
0.00 (0.00%)
Day's Change
0.024 - 0.025
Trading Volume
681,700
Overview
Market Cap
73 Million
Shares Outstanding
3 Billion
Avg Volume
11,385,938
Avg Price (50 Days)
0.03
Avg Price (200 Days)
0.04
PE Ratio
-2.40
EPS
-0.01
Earnings Announcement
20-Feb-2025
Previous Close
0.02
Open
0.03
Day's Range
0.024 - 0.025
Year Range
0.02 - 0.099
Trading Volume
757,700
Price Change Highlight
1 Day Change
0.00%
5 Day Change
4.35%
1 Month Change
-7.69%
3 Month Change
-4.00%
6 Month Change
-17.24%
Ytd Change
15.87%
1 Year Change
10.60%
3 Year Change
-85.10%
5 Year Change
-39.88%
10 Year Change
-40.00%
Max Change
-96.35%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
Australia Faces Economic Pain From Trump Win, Treasurer Warns
2
CEO Morning Brief
Australia raised Fair Trade in Trump Phone Call, Says PM Albanese
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
